Full-Time

Paralegal Corporate and Securities

Posted on 10/31/2025

Clover Health

Clover Health

501-1,000 employees

Medicare Advantage insurer with personalized care

Compensation Overview

$70k - $100k/yr

+ Bonus + ESPP

Remote in USA

Remote

Category
Legal & Compliance (2)
,
Requirements
  • 5-15 years experience as a securities paralegal in a publicly traded company and/or law firm
  • Bachelor’s degree
  • 4+ years of relevant experience (e.g., corporate or transactional support, contract management, project management, document management)
  • Familiarity with the management of corporate records and stock administration
Responsibilities
  • Manage corporate governance processes including board support, section 16 filings and periodic reporting to the SEC
  • Manage corporate filings, stock administration, and international subsidiary corporate calendars
  • Manage the contract execution and document retention processes globally
  • Maintain database of contracts and other corporate records
  • Review, revise and negotiate non-disclosure, procurement and similar contracts in line with Company guidelines
  • Serve as a knowledgeable resource on company policies and procedures, tracking changes and updates for the department
  • Support our legal team in internal investigations and other compliance and risk management functions
  • Assist in legal research and drafting as necessary
  • Work on special projects and other ad hoc duties as requested
Desired Qualifications
  • Paralegal Certificate. Not a must, but nice to have

Clover Health provides Medicare Advantage plans for seniors in the United States, offering coverage that goes beyond traditional Medicare. Its services include personalized care, fitness memberships, home checkups, drug coverage, and Medigap insurance, with revenue coming from member premiums and Medicare reimbursements. The product works by enrolling members in Medicare Advantage and delivering added benefits through a network of healthcare providers and fitness centers, plus home visits and proactive support to manage health. The company differentiates itself with a focus on tailored, attentive care and a growing provider network to enhance member benefits, aiming to improve health outcomes. Its primary goal is to help seniors stay healthier and reduce out-of-pocket costs by combining comprehensive coverage with personalized services.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Nashville, Tennessee

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $749M, up 62% year-over-year with GAAP profit.
  • Membership surged 38% to 155,773, guiding $2.87B revenue in 2026.
  • CMS interoperability rules align with live Kno2 and HealthEx integrations.

What critics are saying

  • 3.51-star CMS rating lags competitors, slashing enrollment in 2026 open period.
  • UnitedHealth and Humana undercut $0 PPO plans in Georgia and Texas markets.
  • $320M cash burns out in 21 months without sustained GAAP profits.

What makes Clover Health unique

  • Clover Assistant aggregates patient data to enable early chronic disease management.
  • Counterpart Health extends AI platform to non-member providers nationwide.
  • HealthEx partnership empowers members to control clinical and claims data sharing.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Clover Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Performance Bonus

Unlimited Paid Time Off

Remote Work Options

Parental Leave

Professional Development Budget

Phone/Internet Stipend

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

-1%
Yahoo Finance
Apr 14th, 2026
Clover Health posts 45% revenue growth to $488M in Q4, tops health insurers

Clover Health reported fourth-quarter revenues of $487.7 million, up 44.7% year on year and exceeding analysts' expectations by 4.4%. The Medicare Advantage provider delivered the strongest performance among 12 tracked health insurance providers, posting the biggest analyst beat and fastest revenue growth in the group. The company added 4,577 customers during the quarter, bringing its total to 113,803. Clover uses proprietary software called Clover Assistant to help physicians manage patient care for seniors. Despite the strong results, shares fell 5.3% following the announcement and currently trade at $2.04, suggesting investor expectations may have been higher than Wall Street's published projections. CEO Andrew Toy said the results validated the company's business model despite headwinds during the year.

Yahoo Finance
Apr 7th, 2026
Clover Health partners with HealthEx to give Medicare members secure access to clinical and claims data

Clover Health has partnered with HealthEx to enable Medicare Advantage members to securely access and share their clinical records and claims data. Built on Counterpart Health infrastructure, the collaboration allows members to connect health information to digital tools like Claude for better care navigation. The partnership addresses healthcare data fragmentation by letting members verify their identity, authorise access and retrieve records through a single streamlined experience, eliminating multiple portal logins. Members can share data with providers, health applications and AI platforms, with each entity governed by its own privacy policy. Counterpart Health powers the underlying interoperability infrastructure, creating a scalable foundation for other health plans. The capability extends Clover's recent interoperability work with Kno2 and supports federal interoperability efforts promoting patient data access rights.

Yahoo Finance
Mar 24th, 2026
Clover Health falls 42% in 6 months as $69M cash burn raises dilution concerns

Clover Health shares have fallen 42.4% over six months to $1.86, prompting concerns about the company's viability. With just $1.92 billion in trailing 12-month revenue, the health insurer struggles with scale disadvantages in an industry where size matters for operational efficiency and customer trust. The company's financial position remains precarious. Clover Health has posted an average free cash flow margin of negative 6.8% over five years, burning $68.98 million in cash last year. With $120.3 million in cash and no debt, it has approximately 21 months of runway remaining. Analysts warn shareholders face potential dilution if the company must raise capital to continue operations, making it a stock to avoid until it demonstrates consistent free cash flow generation.

Yahoo Finance
Feb 27th, 2026
Clover Health guides to first GAAP profit with $2.8B revenue as Medicare members surge 38%

Clover Health Investments has achieved full-year adjusted EBITDA profitability in 2025 and guided to its first year of GAAP net income profitability in 2026, with projected net income of $0–20 million and revenue of $2.81–2.92 billion. The Medicare Advantage insurer grew membership 38% year-over-year to approximately 114,000 members, driven by its risk-bearing model and Clover Assistant platform. Management reported underlying medical cost trends remained well controlled at around 5% annually, excluding pharmacy costs. CEO Andrew Toy said Clover sustained profitability whilst rapidly expanding membership through a model retaining full underwriting risk. The company introduced consolidated gross profit as its primary operating metric, reaching $356 million in 2025 with guidance of $470–510 million for 2026. Clover ended the quarter with $320 million in cash.

Yahoo Finance
Feb 27th, 2026
Clover Health achieves full-year adjusted EBITDA profitability with 38% membership growth

Clover Health has achieved full-year adjusted EBITDA profitability in 2025 whilst delivering 38% membership growth and controlled medical cost trends, despite elevated industry-wide utilisation. CEO Andrew Toy noted the company absorbed first-year dilution from Medicare Advantage membership growth whilst retaining full underwriting risk. The company expects to achieve its first full year of GAAP net income and earnings per share profitability in 2026. Toy emphasised that regulatory pressures weakening competitors have strengthened Clover's positioning, as incumbents reduced benefits and exited markets. Since 2021, Clover has focused on clinical value rather than coding intensity, a strategy now proving advantageous as the broader Medicare Advantage market faces challenges. The company believes its cohort economics are amongst the strongest in the industry.

INACTIVE